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ABSTRACT 
 
The vials filled with Fricke solutions were doped with increasing concentrations of Photogem®, used in 
photodynamic therapy. These vials were then irradiated with low-energy X-rays with doses ranging from 5 to 20 Gy. 
The conventional Fricke solution was also irradiated with the same doses.  The concentration of ferric ions for the 
Fricke and doped-Fricke irradiated solutions were measured in a spectrophotometer at 220 to 340 nm. The results  
showed  that there was an enhancement in the response of the doped-Fricke solution, which was proportional to the 
concentration of the photosensitizer. The use of such procedure for studying the radiosensitizing property of 
photosensitizers based on the production of free radicals is also discussed.  
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INTRODUCTION 
 
Photodynamic therapy (PDT) is a relative new 
treatment used for different types of the tumors 
(Dougherty, 1993, Sibata et al., 2000), in which a 
photosensitizing agent is injected into the patient 
bloodstream or topically applied to the patient skin 
promoting drug accumulation preferentially in the 
tumor. After 24 to 72 h, the tumor is exposed to a 
visible laser light (wavelength around 630 nm). 
The photosensitizing molecules absorb the light 
and produces free radicals and singlet oxygen that 
destroy the cancer cells.  
Photosensitizers have a stable electronic 
configuration corresponding to a singlet state in 
their ground-state energy level. Following the 
absorption of a visible light photon, the molecule 
is promoted to an excited state, which is also a 
singlet state and is short-lived. The photosensitizer 
returns to the ground state by emitting a photon or 
by internal conversion with energy loss as heat. It 
is also possible that the molecule may convert to 
the triplet state via an intersystem crossing, which 
involves a change in the spin of an electron. This 
alternative is the one relevant to PDT. 
There are basically two mechanisms, Type I and 
Type II reactions, by which the triplet state 
photosensitizer can react with the biomolecules 
promoting cellular damage (Oleinick and Evans, 
1998). Type I reaction involves the transfer of the 
electron, or hydrogen atoms producing radical 
forms of the photosensitizer, or the substrate 
(Oleinick and Evans, 1998; Fritsch and Ruzicka, 
2003). These radicals then react rapidly, usually 
with oxygen, resulting in the production of highly 
reactive oxygen species, such as superoxide 
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( −•2O ) (Oleinick and Evans, 1998), the peroxide 
anions ( −22O ) (Oleinick and Evans, 1998; Haylett 
et al., 2003), hydroxyl radicals ( OH -) (Haylett et 
al., 2003; Schaffer et al., 2005) and hydrogen 
peroxide )( 22OH (Haylett et al., 2003). Type II 
reactions produce the electronically excited and 
highly reactive state of oxygen known as singlet 
oxygen ( 21O 0) (Wilson, 2002). Direct interaction 
of the excited triplet state photosensitizer with the 
molecular oxygen (which, unusually, has a triplet 
ground state) results in the photosensitizer 
returning to its singlet ground state and the 
formation of singlet oxygen, which acts as the 
cytotoxic agent. The relative weight of each type 
mechanism is still under debate.  
Besides being an exciting new technique for the 
cancer treatment, the PDT has opened up new 
possibilities to enhance the conventional 
radiotherapy due to its synergistic ionizing 
radiation effects when the target tissue is 
photosensitized with the hematoporphyrin 
normally employed in the PDT (Schaffer et al, 
2002a), The effect on the normal skin of this 
combined modality of the treatment has been 
reported as producing significant increase of skin 
necrosis (Benstead and Moore, 1990). The 
modification of radiosensitivity by porphyrins 
derivatives in several in vivo and in vitro 
experiments have also been studied (Schaffer et 
al., 2001; Schaffer et al., 2002; Schaffer et al., 
2003; Schaffer et al., 2005; Moan and Petersen, 
1981; Bellnier and Dougherty 1986; Zhao et al., 
1986; Zhang et al., 1996; Kostron et al., 1986; 
Chen, 1985; Colasanti et al., 2004; Lukšien÷, 
2004). The mechanism of this radiosensitizing 
effect is not completely understood (Schaffer et 
al., 2005). In vitro data, however, support the 
hypothesis that the radiosensitizing action involves 
OH-radicals (Jori, 1996) in addition to a potential 
impairment of repair mechanisms after sub lethal 
damage of ionizing radiation (Schaffer et al., 
2005).   
To our knowledge, little has been published in the 
enhancement of the radiation effect due to the 
presence of photosensitizer for in vitro studies 
using chemical procedures. The Fricke dosimeter 
(Klassen et al., 1999) is based on the oxidation of 
the ferrous ions (Fe2+) to ferric ions (Fe3+), caused 
by the formation of the free radicals (FR) when the 
solution is irradiated by the ionizing radiation. 
Because the hematoporphyrin acts as 
radiosensitizer and produces FR under irradiation 
with ionizing radiation, this work had the aim to 
use a Fricke solution doped with Photogem® to test 
its sensitivity for those free radicals produced by 
the hematoporphyrin under the    X-ray irradiation 
which yielded Fe3+. 
 
 
MATERIALS AND METHODS  
 
Irradiation Setup 
An X-ray beam from a Pantak x-ray tube set at 70 
kV with a 1.03-mm aluminium filter was used to 
irradiate all the samples in the present work.  The 
energy was verified with a Eurisys (Hewlett 
Packard) Ge spectrometer. The X-ray beam half-
value layer was measured to be 3.1 mm of 
aluminium. The ionization chamber and the Fricke 
dosimeter (with and without the photosensitizer) 
were set at a distance of 500 mm, at the central 
axis of the X-rays beam which was defined as 75 x 
75 mm at the calibration distance. 
 
Absorbed Dose determination 
The mean value of a set of five measurements 
made with a PTW type 2232 plane-parallel 
ionisation chamber inserted in a  Plexiglas 
phantom (110 mm long, 110 mm wide and 80 mm 
deep) was used to calculate the absorbed dose to 
water. Another Plexiglas phantom with the same 
physical dimensions, appropriate to fit the 
vacutainers, was used to irradiate the vials with the 
Fricke dosimeter and Photogem® doped Fricke 
solutions. The doses delivered to the Fricke 
solution and the Photogem® doped Fricke 
solutions were based on the readings of a 
transmission ionisation chambers connected to a 
Farmer NE type 2670 electrometer.  
 
Standard and the Photogem® doped-Fricke 
solutions 
The Fricke solution was prepared with 0.392 g of 
(NH4)2Fe(SO4)2.6H2O, 0.060 g of NaCl, 22 ml of 
H2SO4 and made up to 1,000 ml with Milli-Q 
water (18.2 MΩ.cm). The reference Photogem® 
doped Fricke solution was prepared by adding 
0.0015 g of Photogem® to 1,000 ml of Fricke 
solution. This solution was diluted to prepare 
solutions with concentrations of 2, 4 and 6 mg/l. A 
volume of   3 ml of Fricke solution and Photogem® 
doped Fricke solutions were transferred to a 10 ml 
sterile vacutainer using a needle coupled to a 
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polypropylene tube. The irradiated solutions were 
transferred directly from the vacutainer to a 10 
mm length curvette and the optical densities were 
measured in the range of 220 to 340 nm using a 
Beckman Counter Model DU 640 
spectrophotometer.  
As a first approximation, the doses obtained with 
the Fricke solution were calculated according to 
equations 1, 2 and 3 (Olszanski et al., 2002; IAEA, 
1977; Klassen et al., 1999) 
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Where  ε is the molar  extinction coefficient of Fe3+ 
at 25 oC (218.7 m2  mol-1) (Attix, 1986),  NA is the 
Avogadro’s number, d is the optical pathway (10 
mm), ρ is the solution density (1,022.7 kg.m-3) 
(Olszanski et al., 2002). The factors f1 and f2 were 
used to correct the OD dependence with the 
temperatures,  Ti (°C), of the solution during the 
irradiation, and  TR (°C) during the measurement . 
The value for the chemical yield,  the G(Fe3+) = 
8.93 x1017J-1, was taken from ICRU Report 17 for 
dosimetry of X-Rays Generated at Potentials of 5 to 
150 kV (ICRU, 1970). 
The change in the irradiated solution’s optical 
density, ∆OD, relative to the non-irradiated 
solution at a wavelength of 304 nm (absorption 
peak of Fe3+), of the Fricke solution was calculated 
by subtraction of the average optical density of the 
control (non irradiated Fricke solution). The 
change in the optical density (304 nm) of the 
doped-Fricke solution was obtained by subtraction 
of the average optical density of the non irradiated 
doped-Fricke solution. 
 
Long and short term consistency and 
reproducibility 
The long and short term consistency and 
reproducibility of the Photogem® doped Fricke 
solution was evaluated by irradiating 500 ml 
solution with approximately 40 Gy. The solution 
was stored at room temperature (25-29 oC), and 
the optical densities measurements were made 
during a period of 480 h.  
 
 
RESULTS AND DISCUSSION 
 
General overview 
Fig. 1 shows the spectrum of the irradiated 
Photogem® doped Fricke solution (PDFS). These 
spectra were obtained from the Fricke solution 
doped with 2.5 mg/l of Photogem® and irradiated 
with doses of 5, 7.5, 10, 12.5 and 15 Gy. The 
spectra of the PDFS were quite similar as those 
observed for the conventional Fricke dosimeter. 
The maximum optical densities values occured 
around 224 and 304 nm, indicating that the 
maximum peaks absorption were due to the 
presence of  ferric ions (Fe3+) in the solution.   
Fig. 2 shows the short and long term consistency 
and reproducibility of a Fricke solution doped with 
2.5 mg/l Photogem® irradiated with 40 Gy.  
Results showed an oxidative process in order of 
0.013%/h, which resulted in an increase in the 
response of the doped Fricke solution of 7%. 
Comparable with the conventional stability of the 
Fricke dosimeter, this value was considerably 
higher, since the long term stability of the Fricke 
dosimeter, irradiated with the same X-ray beam 
quality, was in order of ± 1.8% during a period of 
about     600 h. This meant that the presence of the 
photosensitizer affected the reproducibility of the 
Fricke dosimeter.  
Fig. 3 shows the net optical density of the Fricke 
and Photogem® doped Fricke solution as a 
function of the absorbed dose ranged from 7 to 20 
Gy when the Fricke solution (1 liter) was doped 
with  2,   4 and  6 mg of Photogem®. Higher 
concentration of the Photogem® in the Fricke 
solution, showed steeper slope of the curve. 
However, when the concentration of the 
Photogem® was 6 mg/l, the solution became darker 
with some precipitation drifting within the 
solution, which indicated a possible limitation of 
this method.  
 
 
 
Austerlitz, C. et al. 
Braz. arch. biol. technol. v.51 n.2: pp.271-279, Mar./Apr. 2008 
274 
Wave lenght (nm)
220 230 240 250 260 270 280 290 300 310 320 330 340
O
pt
ic
a
l d
e
n
si
ty
0.00
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
5 Gy
10 Gy
12.5 Gy
15 Gy
7.5 Gy
 
 
Figure 1 -  Spectra of Photogem® doped Fricke solutions irradiated with doses between 5 and   15 Gy 
 
 
 
Time interval (hr)
0.1 1 10 100 1000
O
pt
ic
a
l d
e
sn
ity
0.95
0.96
0.97
0.98
0.99
1.00
1.01
1.02
1.03
1.04
1.05
1.06
1.07
1.08
1.09
1.10
%5.3±≈
 
 
Figure 2 -Short and long term stability of the Photogem® doped Fricke solution. 
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Figure 3 -  Enhancement of the response of Fricke solutions doped with different concentrations 
of Photogem® 
 
 
Assuming that the Fricke solution was tissue 
equivalent, the concentrations of Photogem® in the 
Fricke solutions used in this work was close to that 
usually applied in a patient undergoing the PDT 
therapy (1.5 mg Photogem per kg patient weight 
(Bagnato et al, 2002).   The experiments made 
with intravenous administration and the 
distribution of the photosensitizer porfimer 
sodium, Photofrin®, through the body in clinical 
studies of cancer patients have shown that the 
mean serum concentration was of the order of 3.5 
mg/l for an injection based on 2.0 mg/kg (Bellnier 
and Dougherty, 1996). Such concentration was not 
far from those used in this work so that, by the 
reasons described above, a concentration of        4 
mg/l could be used  for the Photogem® doped 
Fricke solution in the experiments involving 
ionization radiation.  
The linear relationship between the optical 
densities and these concentrations irradiated with 
15 Gy is shown in Fig. 4. The presence of 
Photogem® in the Fricke solution enhances its 
response with the absorbed dose.   
 
Chemical reactions in the Fricke dosimeter and 
biological importance of some free radical 
species 
The Fricke dosimeter is an aqueous solution of 
ferrous ions in 0.4 MH2SO4. The ionization 
radiation converts ferrous ions, Fe2+, into ferric 
ions, Fe3+, with a radiation yield, which is 
proportional to the absorbed dose (DF). The 
increase in the concentration of Fe3+ is calculated 
from the increase of the optical density (∆OD) at 
304 nm by the means of the Equation 1.
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Figure 4 -  Optical density as function of the concentration of Photogem® in Fricke solution 
irradiated with 15 Gy 
 
 
The radiation yield of Fe3+ ions in an irradiated 
Fricke dosimeter is expressed in terms of the 
primary products of the radiolysis of the solution 
according to Equation 4 (Klassen et al., 1999). 
 
)()(3)(2)( 223 −++ ++= OHGHGOHGFeG  Eq.4  
 
The yield of Fe3+ produced on the radiolysis of the 
aerated acidified Fe2+ solution gives a measure of 
the total yield of the reactive reducing and 
oxidizing species escaping the radiation track into 
the bulk. The kinetics and the yield of Fe2+ are 
determined by the reactions as below (Harris and 
Pimblott, 2002), 
 
−++ ++→+ OHHFeHFe 2
32
 
Eq. 5 
 
 
−++ +→+ OHFeOHFe 32  Eq. 6 
 
 
−++ ++→+ OHOHFeHOFe 22
3
2
2
 
Eq. 7 
 
 
−++ ++→+ OHOHFeOHFe 322
2
 
Eq. 8 
  
As can be seen from Equation 4, the radicals  
22OH  and OH  - have little effect on the yield of 
Fe3+ observed, as two OH  - radicals or one 22OH  
molecule gives two Fe3+ ions. However, both 
22OH  the OH -  radicals play an important role 
from the biological point of view. The hydroxyl 
free radical is the primary oxidizing species and 
can be used to oxidize and break apart the organic 
molecules. The hydrogen peroxide can also break 
apart the organic molecules through the Fenton’s 
reaction (Satoka, 2001). Equation 8 can be broken 
down into a hydroxide ion and a hydroxyl free 
radical. Hydroxyl radical has a  predominant role 
of the in ionizing radiation damage and minor 
involvement in PDT damage (Henderson and 
Miller, 1986), as well as in  the yield of Fe3+ in the 
Fricke dosimeter (Eq. 4). 
 
Interaction of light and ionizing radiation with 
tissue and with Fricke solution doped with 
Photogem® 
As explained in the introduction, when light 
strikes an oxygenated biological medium doped 
with Photogem®, there is a production of OH  -, 
22OH , 
−•
2O , 
−2
2O  and 2
1O . 
When ionizing radiation interacts with a medium 
doped with a photosensitizer, such as, Photofrin®, 
it has been proposed (Schaffer et al., 2002) that its 
radiosensitivity is connect with the oligomers that 
can efficiently interacted (Jori, 1996) with some 
cytotoxic transient intermediates such as hydroxyl 
radicals, which are known to be generated as a 
result of the primary interaction of the X-ray with 
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the water. In this connection, the Photofrin® acts as 
a radiation amplification factor, by minimizing the 
possible onset of the repair processes, which often 
limit the radio-induced cell damage (Schaffer et 
al., 2002). This mechanism of action has been 
confirmed in the case of another porphyrin, 
namely, gadolinium texaphyrin, which is used as a 
radiosensitizer (Viala et al., 1999; Rowinsky, 
1999).  
When light impinges in a Fricke solution doped 
with the Photogem®, there is an enhancement in 
the response of the dosimeter (Austerlitz et. al., 
2006). In this case, such enhancement is assumed 
to be due to the production of free radicals caused 
by the Type I reaction. When ionizing radiation 
strikes the Fricke solution doped with the 
Photogem®, as proposed by Schaffer (2002), there 
is a radiation amplification factor (here assumed to 
be amplification of free radials) associated with 
the production of the light, including Bharat 
energies that can excite the electrons 
(Padmanabha-Rao, 2001), a kind of Type III 
reaction, which enhances the Fricke dosimeter 
response.   
 
Tumor growth inhibition and Fricke dosimeter 
enhancement 
The effects of the hematoporphyrin derivative, 
light, and 60Co irradiation in a rat glioma model, 
using an in vivo and an in vitro clonogenic assay, 
have been reported by Kostron (1986). It was fond 
that 60Co irradiation in the presence of an 
hematoporphyrin derivative produced a significant 
tumor growth inhibition (up to about 50%) and 
this growth inhibition was directly related to the 
concentration of the hematoporphyrin derivative. 
This result corroborated with observations in a 
recent publication by Schaffer et al. (2002b) where 
Photofrin® II (an hematoporphyrin derivative 
produced by the AXCAN INC - Canada and 
equivalent to Photogem®) was used as a specific 
radiosensitising agent in the patients with the  
bladder cancer (Sokolov, 1995). They observed 
that in similar conditions, the patient injected with 
1 mg/kg had a noticeable increase on the 
radiotherapy response. They claimed a 40% 
reduction of the tumors after the radiotherapy due 
to the presence of the porphyrin. Also, 
experimental work using animals have shown that 
the time for tumor to recover to the original size 
after a certain dose of the radiation is increased by 
almost a factor of two when the Photofrin® II is 
used as an enhancement agent for the radiotherapy 
(Schaffer et al., 2001).  
Henderson (1986) reported the involvement of free 
radical species in the process of cell killing by 
comparing the effect on cell survival following 
photodynamic therapy and gamma irradiation. 
Apparently 90% of the radiotoxic effects could be 
due to the indirect effects of radiation (Walicka, 
2000). In this work pronounced enhancement of 
the Photogem® doped Fricke solution response and 
its direct relationship with the concentration of 
the hematoporphyrin derivative was found. This 
suggested that a Fricke solution doped with 
photosensitizer under X-rays irradiation not only 
detected the free radicals produced by the water 
hydrolysis, but also those from the Type I reaction. 
Therefore, such a dosimeter could be used to 
evaluate the amount of the free radicals produced 
by a particular photosensitizer and its correlation 
with the indirect mechanisms of radiation in 
phototherapy combined with the radiotherapy. 
The Fricke solution could also be used in the 
determination of the concentration of the 
Photogem® in conventional PDT application. The 
combination of the light together with the 
ionization radiation could eventually reveal the 
level of the light dose necessary to promote the 
desired level of the free radical formation that can 
be used in the development of a PDT dosimeter as 
well as the possible degradation of a 
photosensitizer with the ionizing radiation, which 
can be done by irradiating the solution with light 
and ionizing radiation and vice versa. This is a 
subject that still demands a considerable 
investigation and it is under investigation by our 
group. No further study was done concerning the 
overall uncertainty in the determination of 
absorbed dose. However, the reproducibility of the 
Fricke dosimeter did not exceed ± 2.5% (Souza 
and Austerlitz, 2005) and the accuracy in the 
absorbed dose determination with ionization 
chambers was in the order of ± 3.5%. The 
precision in the measurements done with the 
Photogem® doped Fricke solution measurements 
was ± 3.5% (1 sd).  
 
 
CONCLUSIONS  
 
From the results, the following conclusions could 
be drawn: 
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• Under the irradiation with the ionizing radiation,  
there was an enhancement in the response of 
the Fricke solution doped with the Photogem®  
which was proportional to the concentration of 
the  photosensitizer;  
• as the mechanism behind the Fricke dosimetry 
was the formation of the free radicals, the 
enhancement of the response of the 
Photogem® doped Fricke solution was 
attributed to the Type I reaction, and  
• Fricke solution doped with the photosensitizer 
could also be used to compare the production 
of some free radicals from different 
radiosensitizers under the irradiation with 
ionizing radiation. 
 
 
RESUMO 
 
Tubos de ensaio foram preenchidos com a solução 
Fricke dopada com Fotogem® em concentrações 
crescentes; essa hemotoporfirina é utilizada na 
terapia fotodinâmica. Esses tubos foram irradiados 
com doses de 5 a 20 Gy. A solução Fricke 
convencional também foi irradiada com as 
mesmas doses. As concentrações de íons férricos 
nas soluções Fricke convencional e dopadas 
irradiadas foram medidas num espectrofotômetro 
com comprimento de onda entre 220 e 340 nm. Os 
resultados mostraram que quando comparado o 
Fricke convencional com o Fricke dopado 
irradiado, as amostras dopadas demonstraram um 
aumento na resposta da dose absorvida que é 
proporcional a concentração do Photogem® na 
solução Fricke. Concluímos que esse 
procedimento pode ser utilizado para propósitos de 
dosimetria na terapia com radiossensibilizadores . 
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